Microbiome Convergence Research Center (마이크로바이옴융합연구센터)
Results 1-20 of 110 (Search time: 0.004 seconds).
No. | Year | Title | Type |
---|---|---|---|
110 | 2024 | 2024Patent 바이러스 감염질환의 예방 또는 치료를 위한 화합물, 이를 포함하는 조성물 및 이의 용도KR10-2021-0108908 (2021.08.18) / 10-2641463 (2024.02.22)고동준; 김세미 |
Patent |
109 | 2023 | 2023Research Project 폐암 혁신신약타겟 TMPRSS4-특이적 중화항체 유효/선도물질 개발 연구연구책임자 : 김세미 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
108 | 2023 | 2023Research Project 항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2023.01.01 ~ 2023.12.31 |
Research Project |
107 | 2023 | 2023Research Project Hybrid EMT에 의한 암 전이 및 재발 조절기전 연구 및 새로운 항암치료전략 도출연구책임자 : 김세미 / 사업기간 : 2023.03.01 ~ 2024.02.29 |
Research Project |
106 | 2023 | 2023Article TMPRSS4, a type II transmembrane serine protease, as a potential therapeutic target in cancerExperimental and Molecular Medicine, vol. 55, no. 4, pp. 716-724Semi Kim |
Article |
105 | 2023 | 2023Research Project 폐암에서 개인 맞춤 항암 치료를 위한 마이크로바이옴 기반 치료제 프로토타입 개발연구책임자 : 이정수 / 사업기간 : 2023.04.01 ~ 2023.12.31 |
Research Project |
104 | 2022 | 2022Article Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer modelsMolecular Therapy-Oncolytics, vol. 24, pp. 452-466Dongjoon Ko; E Kim; E A Shin; S H Nam; Junghwa Yoon; Jin-Sook Lee; Yunhee Lee; S Park; K Ha; S Y Choi, et al. |
Article |
103 | 2022 | 2022Article TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypesCellular and Molecular Life Sciences, vol. 79, no. 1, pp. 49-49H Sun; E Kim; J Ryu; H Lee; E A Shin; M Lee; H Lee; J H Lee; J H Yoon; D G Song, et al. |
Article |
102 | 2022 | 2022Article Bioconjugated thymol-zinc oxide nanocomposite as a selective and biocompatible antibacterial agent against Staphylococcus speciesInternational Journal of Molecular Sciences, vol. 23, no. 12, pp. 6770-6770J Shin; A Naskar; Dongjoon Ko; Semi Kim; K S Kim |
Article |
101 | 2022 | 2022Research Project 폐암 혁신신약타겟 TMPRSS4 유용성 검증 연구연구책임자 : 김세미 / 사업기간 : 2022.07.01 ~ 2023.06.30 |
Research Project |
100 | 2022 | 2022Research Project EMT-유도 전사인자에 의한 종양 면역억제미세환경 조절 기전 연구연구책임자 : 김세미 / 사업기간 : 2022.03.01 ~ 2023.02.28 |
Research Project |
99 | 2022 | 2022Article Systemic TM4SF5 overexpression in ApcMin/+ mice promotes hepatic portal hypertension associated with fibrosisBMB Reports, vol. 55, no. 12, pp. 609-614J Lee; E Kim; M K Kang; J Ryu; J E Kim; E A Shin; Y Pinanga; K H Pyo; H Lee; E H Lee, et al. |
Article |
98 | 2022 | 2022Research Project 폐암 혁신신약타겟 TMPRSS4-특이적 중화항체 유효/선도물질 개발 연구연구책임자 : 김세미 / 사업기간 : 2022.08.01 ~ 2022.12.31 |
Research Project |
97 | 2022 | 2022Research Project 항암 면역세포 치료기술 개발 = Developemnt of anti-cancer immunotherapy연구책임자 : 윤석란 / 사업기간 : 2022.01.01 ~ 2022.12.31 |
Research Project |
96 | 2022 | 2022Research Project 혁신적 마이크로바이옴 R&D를 위한 in vitro-in vivo 연계 검증 시스템 구축 = Establishing in vitro-in vivo linked validation system for innovative microbiome R&D연구책임자 : 이정수 / 사업기간 : 2022.09.01 ~ 2022.12.31 |
Research Project |
95 | 2021 | 2021Patent 암 진단 또는 치료 표적으로서 LYPD1의 용도KR10-2017-0112830 (2017.09.04) / 10-2237463 (2021.04.01)김세미; 이윤희; 김솔비 |
Patent |
94 | 2021 | 2021Article Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progressionJournal of Pathology, vol. 253, pp. 55-67J Ryu; E Kim; M K Kang; D G Song; E A Shin; H Lee; J W Jung; S H Nam; J E Kim; H J Kim, et al. |
Article |
93 | 2021 | 2021Article Bovine serum albumin-immobilized black phosphorus-based γ-Fe2O3 nanocomposites: a promising biocompatible nanoplatformBiomedicines, vol. 9, no. 8, pp. 858-858A Naskar; S Lee; Dongjoon Ko; Semi Kim; K S Kim |
Article |
92 | 2021 | 2021Article TMEM52B suppression promotes cancer cell survival and invasion through modulating E-cadherin stability and EGFR activityJournal of Experimental & Clinical Cancer Research, vol. 40, no. 1, pp. 58-58Yunhee Lee; Dongjoon Ko; Junghwa Yoon; Y H Lee; Semi Kim |
Article |
91 | 2021 | 2021Article A new surface charge neutralizing nano-adjuvant to potentiate polymyxins in killing Mcr-1 mediated drug-resistant Escherichia coliPharmaceutics, vol. 13, no. 2, pp. 250-250H Cho; A Naskar; S Lee; Semi Kim; K S Kim |
Article |